Moreover, RanBP3 has been reported to be a crucial downstream molecule of MAPK-ERK and PI3K-AKT signal pathways (31), and these signals are over-activated by BCR-ABL in CML. Here, RANBP3 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.